Relay Therapeutics (RLAY) Treasury Shares (2019 - 2025)
Relay Therapeutics (RLAY) reported Treasury Shares of $2.4 million for Q4 2025, down 58.39% year-over-year from $5.8 million in Q4 2024, and down 58.39% on a QoQ basis from $5.8 million in Q4 2024.
Relay Therapeutics (RLAY) has 7 years of Treasury Shares data on file, last reported at $2.4 million in Q4 2025.
- Quarterly Treasury Shares fell 58.39% year-over-year to $2.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.4 million (down 58.39% YoY) and the FY2025 annual result came in at $2.4 million, down 58.39% from the prior year.
- Treasury Shares retreated to $2.4 million in Q4 2025 per RLAY's latest filing, from $5.8 million in the prior quarter.
- Across five years, Treasury Shares topped out at $5.8 million in Q4 2024 and bottomed at $691205.0 in Q4 2021.
- The 5-year median for Treasury Shares is $2.4 million (2025), against an average of $2.7 million.
- The widest annual swing landed in 2021, when Treasury Shares jumped 718.1%; it then slumped 58.39% in 2025.
- Tracing RLAY's Treasury Shares over 5 years: stood at $691205.0 in 2021, then surged by 126.67% to $1.6 million in 2022, then jumped by 90.98% to $3.0 million in 2023, then surged by 94.12% to $5.8 million in 2024, then tumbled by 58.39% to $2.4 million in 2025.
- Per Business Quant, the three latest RLAY Treasury Shares figures stand at $2.4 million (Q4 2025), $5.8 million (Q4 2024), and $3.0 million (Q4 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 700,000.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 34.70 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Relay Therapeutics | 2.53 Bn | 2.53 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.42 Mn |
| Dec 31, 2025 | 2.42 Mn |
| Dec 31, 2024 | 5.81 Mn |
| Dec 31, 2024 | 5.81 Mn |
| Dec 31, 2023 | 2.99 Mn |
| Dec 31, 2023 | 2.99 Mn |
| Dec 31, 2022 | 1.57 Mn |
| Dec 31, 2022 | 1.57 Mn |
| Dec 31, 2021 | 691,205.00 |
| Dec 31, 2021 | 691,205.00 |
| Dec 31, 2020 | 84,489.00 |
| Dec 31, 2020 | 84,489.00 |
| Sep 30, 2020 | 173,818.00 |
| Sep 30, 2020 | 173,818.00 |
| Jun 30, 2020 | 290,477.00 |
| Jun 30, 2020 | 290,477.00 |
| Dec 31, 2019 | 679,158.00 |
| Dec 31, 2019 | 679,158.00 |